Cargando…
From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in developed countries. The incidence of NAFLD in the general population is 30–38% deppending on the geographical area and the diagnostic method used. NAFLD is considered to be the liver manifestation of the metabolic synd...
Autores principales: | MUNTEANU, MIHAI ALEXANDRU, MIRCEA, PETRU ADRIAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620846/ https://www.ncbi.nlm.nih.gov/pubmed/26528002 http://dx.doi.org/10.15386/cjmed-277 |
Ejemplares similares
-
Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016) -
Dysregulated lipid metabolism links NAFLD to cardiovascular disease
por: Deprince, Audrey, et al.
Publicado: (2020) -
The Link between NAFLD and Metabolic Syndrome
por: Radu, Fabiana, et al.
Publicado: (2023) -
Artificial Intelligence in NAFLD: Will Liver Biopsy Still Be Necessary in the Future?
por: Zhang, Lei, et al.
Publicado: (2022) -
NAFLD and cardiovascular disease
por: Martins, Elisabete, et al.
Publicado: (2018)